Research results reported by investigators based at the Department of Genetics & Microbiology, University of Barcelona, Spain, have shown that whole exome sequencing (WES) continues… Read More »Whole exome sequencing (WES) continues to yield significant efficiencies in clinical identification of inherited retinal degenerations.
Dutch biotechnology company uniQure B.V., (NASDAQ:QURE), Amsterdam, The Netherlands, has announced that it will not pursue the renewal of its Glybera (alipogene tiparvovec) marketing authorization… Read More »Uncertainty for gene therapy following withdrawal from market of Europe’s first gene therapeutic
Results from an industry Phase III non-inferiority study of a new single chain antibody fragment (RTH258), designed to inhibit all VEGF-A isoforms, appears to achieve… Read More »Experimental AMD drug may require less regular injections than competing anti-VEGF treatments, subject to data yet to be released
The National Eye Institute of the US National Institutes of Health (NIH) has launched an ambitious competition for researchers to build a working model of… Read More »National Eye Institute (NEI) launches research competition to develop a 3-D retina organoid
by Dr. Gearóid Tuohy Dear EURETINA Members, A very warm welcome to the July 5th, 2017 edition of EURETINA’s web-based digital magazine, “EURETINA… Read More »July 5th, 2017: “EURETINA-Brief”© Issue No. 156
Dutch biotechnology company ProQR Therapeutcis N.V., (NASDAQ:PRQR), Leiden, The Netherlands, has announced the receipt of “fast-track” designation from the FDA for their clinical stage development… Read More »Dutch company ProQR announces the receipt of FDA authorisation to initiate Phase I/II study for Leber congenital amaurosis, type 10 (LCA10)
Research conducted on behalf of the UK Diabetic Retinopathy Electronic Medical Record (UK DR EMR) Users Group has shown that the rate of developing “treatment-requiring”… Read More »UK multicentre real-world study demonstrates a sharp increase in diabetic macular oedema following cataract surgery
A research project conducted at the University of Bern, led by Dr. Martin S. Zinkernagel, Dr. Denise C. Zysset-Burri and Prof. Dr. Dr. Sebastian Wolf,… Read More »Swiss research team demonstrates changes of the intestinal mircobiome may be associated with age-related macular degeneration (AMD)
by Dr. Gearóid Tuohy Dear EURETINA Members, A very warm welcome to the June 13th, 2017 edition of EURETINA’s web-based digital magazine, “EURETINA… Read More »June 13th, 2017: “EURETINA-Brief”© Issue No. 155
Spark Therapeutics (NASDAQ:ONCE), Philadelphia, PA, has announced the filing of a rolling Biologics License Application (BLA) with the US FDA for their novel gene therapy… Read More »Spark Therapeutics files rolling BLA with FDA for new gene therapy product to treat RPE-mediated retinal degeneration